Näytetään 1 - 5 yhteensä 5 tuloksesta haulle 'Seyed Reza Mousavi (13223324)', hakuaika: 0,01s Tarkenna hakua
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. Tekijä Seyed Reza Mousavi (13223324)

    Julkaistu 2025
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. Tekijä Seyed Reza Mousavi (13223324)

    Julkaistu 2025
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. Tekijä Seyed Reza Mousavi (13223324)

    Julkaistu 2025
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. Tekijä Seyed Reza Mousavi (13223324)

    Julkaistu 2025
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. Tekijä Seyed Reza Mousavi (13223324)

    Julkaistu 2025
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: